Use of Lodoz in Patients with Arterial Hypertension and Metabolic Disorders: Results of the Program LOTOS
Article reviews problem of selection of antihypertensive medications for patients with arterial hypertension and concomitant disorders of metabolism. Results of the program LOTOS program are discussed. Aim of the program was to assess antihypertensive effectiveness, safety and influence on life quality of treatment with Lodoz. Patients of various age groups with arterial hypertension of 1st and 2nd degree were included. We demonstrated, that in most of hypertensive patients with concomitant metabolic disorders treatment with Lodoz provides target blood pressure level, without increase of fasting serum glucose, serum lipids, and without decrease of plasma potassium. Features of Lodoz are: high antihypertensive effectiveness, good safety and tolerability, neutral action on metabolism. It makes possible to use this medication in hypertensive patients with concomitant metabolic disorders.